Unblind? Don't Need To. Approach overseas could be to push for approvals for m/m. Hey, WE DID ACHIEVE STATISTICAL SIGNIFICANCE on NEWS2 issues, and globally, new cases are rising (m/m is relevant) and death rates are declining (relevant to s/c). Hey Philippines. Canada, UK, lets give folks leronlimab in early stages m/m, where Leronlimab achieved Stat Sig, and prevent m/m for advancing to s/c!!!!!
No unblinding, no influence upon Phase III s/c enrollments.